Abivax SA American Depositary Shares (NYSE: ABVX) — Healthcare · Share Price, Chart & Market Data
About: ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $111.97 (-2.26%)
ABVXAbivax SA American Depositary Shares
Loading watchlist status…
Trade ABVX now
Abivax SA American Depositary Shares share price
ABVX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 6:36 pm GMT+0
ABVX price performance
0.485%
5D
9.271%
1M
-16.297%
YTD
1,442.287%
1Y
ABVX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 6:36 pm GMT+0
ABVX details
ABVX Market Signals